Issue 19, 2019

Microphysiological lung models to evaluate the safety of new pharmaceutical modalities: a biopharmaceutical perspective

Abstract

The lung is a complex organ; it is both the initial barrier for inhaled agents and the site of metabolism and therapeutic effect for a subset of systemically administered drugs. Comprised of more than 40 cell types that are responsible for various important functions, the lung's complexity contributes to the subsequent challenges in developing complex in vitro co-culture models (also called microphysiological systems (MPS), complex in vitro models or organs-on-a-chip). Although there are multiple considerations and limitations in the development and qualification of such in vitro systems, MPS exhibit great promise in the fields of pharmacology and toxicology. Successful development and implementation of MPS models may enable mechanistic bridging between non-clinical species and humans, and increase clinical relevance of safety endpoints, while decreasing overall animal use. This article summarizes, from a biopharmaceutical industry perspective, essential elements for the development and qualification of lung MPS models. Its purpose is to guide MPS developers and manufacturers to expedite MPS utilization for safety assessment in the biopharmaceutical industry.

Graphical abstract: Microphysiological lung models to evaluate the safety of new pharmaceutical modalities: a biopharmaceutical perspective

Article information

Article type
Tutorial Review
Submitted
24 May 2019
Accepted
27 Tem 2019
First published
30 Ağu 2019

Lab Chip, 2019,19, 3152-3161

Microphysiological lung models to evaluate the safety of new pharmaceutical modalities: a biopharmaceutical perspective

G. R. Ainslie, M. Davis, L. Ewart, L. A. Lieberman, D. J. Rowlands, A. J. Thorley, G. Yoder and A. M. Ryan, Lab Chip, 2019, 19, 3152 DOI: 10.1039/C9LC00492K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements